ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 247 filers reported holding ACCELERON PHARMA INC in Q2 2020. The put-call ratio across all filers is 0.88 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $56,912,000 | +9661.9% | 453,520 | +6556.7% | 0.37% | +2366.7% |
| Q1 2020 | $583,000 | -98.5% | 6,813 | -99.2% | 0.02% | -99.0% |
| Q4 2018 | $39,938,000 | -54.3% | 905,017 | -40.8% | 1.52% | -35.0% |
| Q3 2018 | $87,459,000 | +18.0% | 1,528,205 | 0.0% | 2.34% | +20.3% |
| Q2 2018 | $74,149,000 | +25.1% | 1,528,205 | +0.8% | 1.94% | +17.0% |
| Q1 2018 | $59,286,000 | -13.6% | 1,516,259 | -6.2% | 1.66% | -27.0% |
| Q4 2017 | $68,594,000 | -43.1% | 1,616,259 | -50.0% | 2.27% | -1.3% |
| Q3 2017 | $120,638,000 | +458.1% | 3,232,518 | +354.5% | 2.30% | +111.7% |
| Q2 2017 | $21,615,000 | +23.0% | 711,259 | +7.1% | 1.09% | +8.7% |
| Q1 2017 | $17,572,000 | +11.1% | 663,857 | +7.1% | 1.00% | -11.0% |
| Q4 2016 | $15,822,000 | -25.9% | 619,987 | +5.1% | 1.12% | -18.4% |
| Q3 2016 | $21,348,000 | +4.2% | 589,890 | -2.2% | 1.38% | -3.0% |
| Q2 2016 | $20,491,000 | -3.3% | 603,036 | -24.9% | 1.42% | -23.6% |
| Q1 2016 | $21,192,000 | +57.4% | 803,036 | +190.9% | 1.86% | +86.6% |
| Q4 2015 | $13,460,000 | -2.1% | 276,036 | -50.0% | 1.00% | +81.4% |
| Q3 2015 | $13,746,000 | +57.4% | 552,072 | +100.0% | 0.55% | +4.4% |
| Q2 2015 | $8,734,000 | -31.7% | 276,036 | -17.9% | 0.53% | -47.1% |
| Q1 2015 | $12,790,000 | +3.4% | 336,036 | +5.8% | 0.99% | -4.2% |
| Q4 2014 | $12,375,000 | -8.0% | 317,636 | -28.6% | 1.04% | -28.2% |
| Q3 2014 | $13,457,000 | +32.0% | 445,000 | +48.3% | 1.44% | +44.5% |
| Q2 2014 | $10,191,000 | – | 300,000 | – | 1.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Darwin Global Management, Ltd. | 938,490 | $120,070,000 | 33.50% |
| Foresite Capital Management III, LLC | 108,630 | $13,898,000 | 16.15% |
| Octagon Capital Advisors LP | 112,363 | $14,376,000 | 4.98% |
| Artal Group S.A. | 1,400,000 | $179,116,000 | 3.84% |
| Avoro Capital Advisors LLC | 1,550,000 | $198,307,000 | 3.42% |
| Affinity Asset Advisors, LLC | 45,000 | $5,757,000 | 3.05% |
| NWI MANAGEMENT LP | 200,000 | $25,588,000 | 2.54% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 71,000 | $9,063,000 | 2.48% |
| FARALLON CAPITAL MANAGEMENT LLC | 2,600,000 | $332,644,000 | 2.00% |
| Parkman Healthcare Partners LLC | 52,458 | $6,711,000 | 1.72% |